SUMMARY
INTRODUCTION
Recurrent pregnancy loss (RPL) was traditionally described as 3 or more clinically diagnosed consecutive pregnancy losses prior to the 20 th gestational week (molar and ectopic pregnancies were not included in the definition) (1) . Since similar etiologic factors have been identified between 2 or ≥ 3 pregnancy losses has been detected in recent years, RPL has been defined as ≥ 2 consecutive pregnancy losses and etiological investigation has been recommended (2) (3) (4) .
Two or 3 consecutive pregnancy losses among the female population of child-bearing age have been observed at an incidence of 5% and 0.3-1%, respectively (1, 5) . A consensus has not been reached on a uniform screening algorithm related to the etiological evaluation of RPL. Although many etiologic factors (genetic, anatomic, hormonal, environmental and immunological) have been implicated for the development of this condition with complex pathophysiological characteristics, any distinct pathology cannot be detected in 50% of the cases (6) . Successful pregnancy outcomes have been reported in 71-76% of the cases in the later period (7, 8) .
From etiological perspective, detection of any cause of repeated miscarriages and to find a treatable abnormality in couples with a history of RPL is important considerations. Etiological factors can demonstrate significant variations among populations because of genetic polymorphism. Aim of the present study is to evaluate patients with RPL in our region regarding etiological factors.
MATERIAL and METHODS
The records of patients which investigated for RPL in clinically fetal losses which weighing less than 500 g or miscarriages before the 20 th gestational age (6) . Five hundred and seventy-two patients consulted to our 
RESULTS
Mean age (29.7 ± 6.6 years), number of miscarriages (3.2 ± 1.3) and demographic data of the patients are shown in Table I . At least one etiologic factor was detected in 50 (43.9%) patients, while any etiologic factor was not found in 64 (56.1%) patients. Table II . Evaluation of etiologic causes of recurrent pregnancy loss 3-5% (1, 9) . Alp et al. (10) analyzed karyotypes of 434 couples with a history of RPL in our region and reported chromosomal aberrations in 6.9% of one of the parents.
Minor chromosomal aberrations were not included in their study and other etiologic factors were not analyzed.
In this study, major parental chromosomal abnormalities were detected in 3.5% of the cases and qh positivity was observed in heterochromatic centromeres of the 9 th chromosome in 23.7% of the female and 17.5% of the male partners. Polymorphisms have been described on heterochromatic centromeric regions of the chromosomes (11) . It has been suggested that this type of variations have no phenotypic impact on carriers but they occurs more frequently in infertile couples or patients with history of RPL (12) . However, Blumberg et al (11) suggested heterochromatic polymorphic variants of chromosomes have not any significance in cases with RPL. Minor aberrations such as qh positivity are not usually reported. However in this study because of its high incidence, we thought that it should be evaluated in future studies in consideration of genetic differences among the study population or its role as an etiologic factor.
Congenital uterine abnormalities were detected in 3-7% of normal female population whereas in 10-15%
in cases with RPL. Most frequently reported mullerian anomalies have been septate uterus and bicornuate uterus. Especially the relationship between septate uterus and RPL was demonstrated (5, 13, 14) . In the present study the frequency of congenital uterine anomalies were detected as 12.3%.
Predisposition to coagulopathy secondary to physiological alterations in coagulation factors in pregnancy is aggravated in the presence of hereditary thrombophilic mutations. Hereditary thrombophilia has been reported to be correlated with increased incidence of complicated outcomes as venous thrombosis, pulmonary embolism, miscarriages, intrauterine fetal loss, intrauterine growth restriction (IUGR) and preeclampsia (6, 15) . Controversial outcomes have been published in the literature related to the association between thrombophilic disorders and RPL.
However two metaanalyses recommended to investigate patients for FVL mutation, prothrombin gene mutation and protein S deficiency (16, 17) . Prevalence of protein it is difficult to diagnose protein S deficiency (18, 19) .
Because of rarity of protein S deficiency and abovementioned difficulties, protein S deficiency is not evaluated in the present study.
Since a statistically significant correlation could not be demonstrated between fetal loss and MTHFR gene mutation, protein C and antithrombin 3 deficiencies, the indicated thrombophilic disorders were not included in the study (16, 17) . In our country, the incidence of FVL mutation positivity has been reported as 7.9-18.2% and prothrombin gene mutation as 1.7-5.37% (20, 22) . In cases with demonstrated prothrombin gene or FVL mutations, thrombophylaxis has been recommended because of improvements in pregnancy outcomes. In this study, we detected rates of FVL and prothrombin gene mutations as 6.1% and 5.3%, respectively.
Some autoimmune diseases have been blamed as an etiologic factor for RPL. However only in the diagnosis of antiphospholipid antibodies syndrome history of RPL is a criteria (23) . In the literature, incidence of the presence of antiphospholipid antibodies has been reported to be significantly higher in cases with RPL when compared with the general population and its inclusion in etiological surveys has been recommended.
In women with antiphospholipid antibody positivity, increased risks of IUGR and prematurity have been reported (1, 23) . In this study, antiphospholipid antibody positivity was observed in 8.8% of the patients in compliance with the literature.
Although controversial, associations among DM and thyroid endocrinopathy with infertility, congenital anomalies and RPL have been reported in the literature (1, 6, (24) (25) (26) . In this study, type 2 DM or thyroid endocrinopathy was observed in 14.9% of the patients. Apart from this, endocrinopathies as luteal phase defect, hyperprolactinemia, polycystic ovarian syndrome, insulin resistance have been implicated among etiologic factors (27, 28) . Endocrinologic factors excepting DM and thyroid endocrinopathy were not investigated in this study.
Our study had some limitations including its retrospective design, scarce number of cases and absence of any control group. However, we think that this survey will be especially helpful in the evaluation of cases with RPL in our region.
In conclusion, in the assessment of cases with RPL in our region, we have detected genetic, anatomic and immunologic factors in cases with RPL comparable to those found in the literature. Detection of 9qh positivity in 39 (34.2%) parents reminded us the need for further studies in order to understand whether 9 qh positivity is related to the genetic polymorphism in the studied population? or is it associated with RPL?.
